JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
FATE - Fate Therapeutics Inc.
USD | NASDAQ | Healthcare
Summary
Summary FATE Stock
Financials
Financials FATE Stock
Loading...
Loading...
Income Statement
Income Statement FATE Stock
Balance Sheet
Balance Sheet FATE Stock
Cash Flow Statement
Cash Flow Statement FATE Stock
Loading...
Loading...
FATE Financials - Fate Therapeutics Income & Cash Flow | Ledgeburg
Home
Stocks
Fate Therapeutics Inc. (FATE)
Financials
Financials of FATE
Loading...
Loading...
Loading...
Loading...
Revenue
$6.646M
Operating Income
$-147.704M
Net Income
$-136.315M
Share Count (Basic)
118.789974M
Operating Cash Flow
$-106.084M
Free Cash Flow
$-112.037M
Cash And Short-Term Equivalents
$203.657M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
80M
100M
FY2021
FY2022
FY2023
FY2024
Revenue $USD
0
500K
1M
1.5M
2M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-300M
-250M
-200M
-150M
Annual
Quarterly
Margins
Gross
Operating
Net
-2000%
-1500%
-1000%
-500%
FY2025
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-38M
-36M
-34M
-32M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-2600%
-2400%
-2200%
-2000%
-1800%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26